Innovation Pharmaceuticals Inc. (IPIX)
OTCMKTS: IPIX · Delayed Price · USD
0.0030
+0.0010 (50.00%)
Apr 26, 2024, 3:33 PM EDT - Market closed
IPIX Ratios and Metrics
Market cap in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
| Year | Current | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 - 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Capitalization | 2 | 10 | 16 | 83 | 97 | 32 | 85 | 122 | 162 | 297 | 171 | Upgrade
|
| Market Cap Growth | - | -35.24% | -81.23% | -14.47% | 206.85% | -62.81% | -30.23% | -24.76% | -45.31% | 73.85% | 461.93% | Upgrade
|
| Enterprise Value | 1 | 9 | 12 | 75 | 94 | 33 | 85 | 120 | 158 | 291 | 168 | Upgrade
|
| PE Ratio | -8.69 | -3.19 | -2.18 | -4.44 | -13.88 | -3.50 | -5.21 | -7.87 | -12.64 | -22.59 | -20.71 | Upgrade
|
| PS Ratio | - | - | 867.77 | - | 230.01 | - | - | - | - | - | - | Upgrade
|
| PB Ratio | 1.33 | 4.96 | 3.30 | 11.08 | 66.55 | -7.68 | -39.64 | -83.47 | 54.79 | 42.27 | 141.62 | Upgrade
|
| P/FCF Ratio | -3.03 | -4.67 | -2.46 | -8.70 | -22.91 | -4.94 | -6.37 | -10.14 | -15.77 | -21.95 | -16.77 | Upgrade
|
| P/OCF Ratio | -3.12 | -4.80 | -2.49 | -8.76 | -23.41 | -5.01 | -6.42 | -10.43 | -16.43 | -22.72 | -22.74 | Upgrade
|
| EV/Sales Ratio | - | - | 684.16 | - | 221.59 | - | - | - | - | - | - | Upgrade
|
| EV/EBITDA Ratio | -3.41 | -3.45 | -1.92 | -8.67 | -22.53 | -5.77 | -5.39 | -8.04 | -13.65 | -23.15 | -21.66 | Upgrade
|
| EV/EBIT Ratio | -2.78 | -3.02 | -1.82 | -8.31 | -20.68 | -5.42 | -5.25 | -7.83 | -13.17 | -22.43 | -20.88 | Upgrade
|
| EV/FCF Ratio | -2.73 | -4.09 | -1.94 | -7.83 | -22.07 | -5.15 | -6.34 | -9.97 | -15.35 | -21.47 | -16.48 | Upgrade
|
| Debt / Equity Ratio | 0.60 | 0.36 | 0.11 | 0.25 | 1.68 | -0.68 | -1.88 | -2.76 | 1.36 | 0.58 | 3.35 | Upgrade
|
| Debt / EBITDA Ratio | -0.15 | -0.10 | -0.08 | -0.22 | -0.59 | -0.34 | -0.13 | -0.14 | -0.17 | -0.16 | -0.26 | Upgrade
|
| Debt / FCF Ratio | -0.12 | -0.12 | -0.08 | -0.20 | -0.58 | -0.30 | -0.15 | -0.17 | -0.20 | -0.15 | -0.20 | Upgrade
|
| Quick Ratio | 0.17 | 0.30 | 0.79 | 1.56 | 0.82 | 0.08 | 0.29 | 0.39 | 0.75 | 1.15 | 0.52 | Upgrade
|
| Current Ratio | 0.19 | 0.33 | 0.82 | 1.63 | 0.83 | 0.09 | 0.30 | 0.42 | 0.79 | 1.20 | 0.58 | Upgrade
|
| Asset Turnover | 0.00 | 0 | 0.00 | 0 | 0.05 | 0 | 0 | 0 | 0 | 0 | 0 | Upgrade
|
| Interest Coverage | -15.93 | -51.56 | -60.18 | -1.86 | -17.83 | -2.94 | -69.02 | -75.92 | -62.64 | -64.14 | -38.28 | Upgrade
|
| Return on Equity (ROE) | -169.02% | -155.37% | -151.40% | -249.42% | -479.48% | 219.69% | 760.67% | 1061.20% | -433.60% | -187.14% | -683.83% | Upgrade
|
| Return on Assets (ROA) | -29.46% | -42.14% | -69.00% | -130.98% | -75.80% | -224.20% | -250.15% | -170.50% | -112.29% | -91.80% | -76.00% | Upgrade
|
| Return on Capital (ROIC) | -137.21% | -127.39% | -132.28% | -96.10% | -118.30% | 292.30% | 10808.53% | -2748.39% | -253.79% | -143.22% | -249.01% | Upgrade
|
| Earnings Yield | -127.36% | -31.32% | -45.85% | -22.51% | -7.21% | -28.61% | -19.19% | -12.71% | -7.91% | -4.43% | -4.83% | Upgrade
|
| FCF Yield | -132.94% | -21.41% | -40.72% | -11.50% | -4.37% | -20.24% | -15.71% | -9.86% | -6.34% | -4.56% | -5.96% | Upgrade
|
| Dividend Yield | 0.49% | 0.85% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | Upgrade
|
| Payout Ratio | -10.88% | -2.71% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | Upgrade
|
| Buyback Yield / Dilution | -2.85% | -0.38% | -30.48% | -62.73% | -33.14% | -23.33% | -13.53% | -6.15% | -4.19% | -9.56% | -10.60% | Upgrade
|
| Total Shareholder Return | -2.85% | 0.47% | -30.48% | -62.73% | -33.14% | -23.33% | -13.53% | -6.15% | -4.19% | -9.56% | -10.60% | Upgrade
|
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.